- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Peptide Therapeutics market will register a 4.4% CAGR in terms of revenue, the global market size will reach $ 36760 million by 2025, from $ 30990 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Peptide Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Therapeutics market by type, application, key manufacturers and key regions and countries.
This study considers the Peptide Therapeutics value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Injection
Oral
Other
The proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Cancer
Metabolic Disorders
Central Nervous System
Other
The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Allergan
Eli Lilly
Takeda
Teva
Novo Nordisk
Ipsen
Novartis
AbbVie
AstraZeneca
Ferring
The Medicines
J & J
Merck
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Peptide Therapeutics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Peptide Therapeutics market by identifying its various subsegments.
Focuses on the key global Peptide Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Peptide Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Peptide Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peptide Therapeutics Consumption 2015-2025
2.1.2 Peptide Therapeutics Consumption CAGR by Region
2.2 Peptide Therapeutics Segment by Type
2.2.1 Injection
2.2.2 Oral
2.2.3 Other
2.3 Peptide Therapeutics Consumption by Type
2.3.1 Global Peptide Therapeutics Consumption Market Share by Type (2015-2020)
2.3.2 Global Peptide Therapeutics Revenue and Market Share by Type (2015-2020)
2.3.3 Global Peptide Therapeutics Sale Price by Type (2015-2020)
2.4 Peptide Therapeutics Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Peptide Therapeutics Consumption by Application
2.5.1 Global Peptide Therapeutics Consumption Market Share by Type (2015-2020)
2.5.2 Global Peptide Therapeutics Value and Market Share by Type (2015-2020)
2.5.3 Global Peptide Therapeutics Sale Price by Type (2015-2020)
3 Global Peptide Therapeutics by Company
3.1 Global Peptide Therapeutics Sales Market Share by Company
3.1.1 Global Peptide Therapeutics Sales by Company (2018-2020)
3.1.2 Global Peptide Therapeutics Sales Market Share by Company (2018-2020)
3.2 Global Peptide Therapeutics Revenue Market Share by Company
3.2.1 Global Peptide Therapeutics Revenue by Company (2018-2020)
3.2.2 Global Peptide Therapeutics Revenue Market Share by Company (2018-2020)
3.3 Global Peptide Therapeutics Sale Price by Company
3.4 Global Peptide Therapeutics Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Peptide Therapeutics Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Peptide Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Peptide Therapeutics by Regions
4.1 Peptide Therapeutics by Regions
4.2 Americas Peptide Therapeutics Consumption Growth
4.3 APAC Peptide Therapeutics Consumption Growth
4.4 Europe Peptide Therapeutics Consumption Growth
4.5 Middle East & Africa Peptide Therapeutics Consumption Growth
5 Americas
5.1 Americas Peptide Therapeutics Consumption by Countries
5.1.1 Americas Peptide Therapeutics Consumption by Countries (2015-2020)
5.1.2 Americas Peptide Therapeutics Value by Countries (2015-2020)
5.2 Americas Peptide Therapeutics Consumption by Type
5.3 Americas Peptide Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Peptide Therapeutics Consumption by Regions
6.1.1 APAC Peptide Therapeutics Consumption by Regions (2015-2020)
6.1.2 APAC Peptide Therapeutics Value by Regions (2015-2020)
6.2 APAC Peptide Therapeutics Consumption by Type
6.3 APAC Peptide Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Peptide Therapeutics by Countries
7.1.1 Europe Peptide Therapeutics Consumption by Countries (2015-2020)
7.1.2 Europe Peptide Therapeutics Value by Countries (2015-2020)
7.2 Europe Peptide Therapeutics Consumption by Type
7.3 Europe Peptide Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Peptide Therapeutics by Countries
8.1.1 Middle East & Africa Peptide Therapeutics Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Peptide Therapeutics Value by Countries (2015-2020)
8.2 Middle East & Africa Peptide Therapeutics Consumption by Type
8.3 Middle East & Africa Peptide Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Peptide Therapeutics Distributors
10.3 Peptide Therapeutics Customer
11 Global Peptide Therapeutics Market Forecast
11.1 Global Peptide Therapeutics Consumption Forecast (2021-2025)
11.2 Global Peptide Therapeutics Forecast by Regions
11.2.1 Global Peptide Therapeutics Forecast by Regions (2021-2025)
11.2.2 Global Peptide Therapeutics Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Peptide Therapeutics Forecast by Type
11.8 Global Peptide Therapeutics Forecast by Application
12 Key Players Analysis
12.1 Sanofi
12.1.1 Company Information
12.1.2 Peptide Therapeutics Product Offered
12.1.3 Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Latest Developments
12.2 Allergan
12.2.1 Company Information
12.2.2 Peptide Therapeutics Product Offered
12.2.3 Allergan Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Allergan Latest Developments
12.3 Eli Lilly
12.3.1 Company Information
12.3.2 Peptide Therapeutics Product Offered
12.3.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Eli Lilly Latest Developments
12.4 Takeda
12.4.1 Company Information
12.4.2 Peptide Therapeutics Product Offered
12.4.3 Takeda Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Takeda Latest Developments
12.5 Teva
12.5.1 Company Information
12.5.2 Peptide Therapeutics Product Offered
12.5.3 Teva Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Teva Latest Developments
12.6 Novo Nordisk
12.6.1 Company Information
12.6.2 Peptide Therapeutics Product Offered
12.6.3 Novo Nordisk Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Novo Nordisk Latest Developments
12.7 Ipsen
12.7.1 Company Information
12.7.2 Peptide Therapeutics Product Offered
12.7.3 Ipsen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Ipsen Latest Developments
12.8 Novartis
12.8.1 Company Information
12.8.2 Peptide Therapeutics Product Offered
12.8.3 Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis Latest Developments
12.9 AbbVie
12.9.1 Company Information
12.9.2 Peptide Therapeutics Product Offered
12.9.3 AbbVie Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 AbbVie Latest Developments
12.10 AstraZeneca
12.10.1 Company Information
12.10.2 Peptide Therapeutics Product Offered
12.10.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 AstraZeneca Latest Developments
12.11 Ferring
12.11.1 Company Information
12.11.2 Peptide Therapeutics Product Offered
12.11.3 Ferring Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Ferring Latest Developments
12.12 The Medicines
12.12.1 Company Information
12.12.2 Peptide Therapeutics Product Offered
12.12.3 The Medicines Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 The Medicines Latest Developments
12.13 J & J
12.13.1 Company Information
12.13.2 Peptide Therapeutics Product Offered
12.13.3 J & J Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 J & J Latest Developments
12.14 Merck
12.14.1 Company Information
12.14.2 Peptide Therapeutics Product Offered
12.14.3 Merck Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Merck Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Peptide Therapeutics Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players o
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
